
    
      A prospective, multi-center, investigator sponsored, randomized controlled trial, 15 sites
      join in in China, 908 subjects will be enrolled.

      A descriptive analysis will be performed on primary endpoint, containing frequency of number
      and percentage of patients. A two proportion equality test will be conducted to explore
      whether incidence rates are different.

      Descriptive statistics including number (N), mean, median, standard deviation, minimum and
      maximum, will be produced for all continuous variables. Frequency tables of number (N) and
      percentage of subjects will be produced for all categorical variables.
    
  